Variant report

Variant	nsv579595
Chromosome Location	chr19:41447332-41508020
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr19:41506351-41506450	HepG2	liver:	n/a	n/a
2	ARID3A	chr19:41486058-41486085	HepG2	liver:	n/a	n/a
3	ARID3A	chr19:41507311-41507499	K562	blood:	n/a	n/a
4	ATF1	chr19:41468671-41468771	K562	blood:	n/a	n/a
5	ATF3	chr19:41506140-41506734	HCT-116	colon:	n/a	n/a
6	ATF3	chr19:41506069-41506786	HCT-116	colon:	n/a	n/a
7	ATF3	chr19:41506267-41506508	K562	blood:	n/a	n/a
8	ATF3	chr19:41468329-41468885	A549	lung:	n/a	n/a
9	BACH1	chr19:41488176-41489166	H1-hESC	embryonic stem cell:	n/a	n/a
10	BCL3	chr19:41468291-41469001	A549	lung:	n/a	n/a
11	BCL3	chr19:41468223-41469050	A549	lung:	n/a	n/a
12	BHLHE40	chr19:41507420-41507421	K562	blood:	n/a	n/a
13	BRCA1	chr19:41465957-41466156	GM12878	blood:	n/a	n/a
14	CBX3	chr19:41482345-41482685	K562	blood:	n/a	n/a
15	CBX3	chr19:41505993-41506787	HCT-116	colon:	n/a	n/a
16	CBX3	chr19:41460404-41460899	K562	blood:	n/a	n/a
17	CBX3	chr19:41460434-41460907	K562	blood:	n/a	n/a
18	CEBPB	chr19:41488308-41488880	A549	lung:	n/a	chr19:41488609-41488620 chr19:41488607-41488620 chr19:41488609-41488618 chr19:41488607-41488618 chr19:41488607-41488620
19	CEBPB	chr19:41468165-41469078	A549	lung:	n/a	chr19:41468797-41468810
20	CEBPB	chr19:41506884-41506987	IMR90	lung:	n/a	n/a
21	CEBPB	chr19:41506068-41507138	HCT-116	colon:	n/a	chr19:41506435-41506446
22	CEBPB	chr19:41488434-41488797	HepG2	liver:	n/a	chr19:41488609-41488620 chr19:41488607-41488620 chr19:41488609-41488618 chr19:41488607-41488618 chr19:41488607-41488620
23	CEBPB	chr19:41486262-41486477	HepG2	liver:	n/a	n/a
24	CEBPB	chr19:41506284-41507442	A549	lung:	n/a	chr19:41506435-41506446
25	CEBPB	chr19:41506205-41506669	MCF-7	breast:	n/a	chr19:41506435-41506446
26	CEBPB	chr19:41506268-41506934	HepG2	liver:	n/a	chr19:41506435-41506446
27	CEBPB	chr19:41506263-41507465	K562	blood:	n/a	chr19:41506435-41506446
28	CEBPB	chr19:41488440-41489019	H1-hESC	embryonic stem cell:	n/a	chr19:41488609-41488620 chr19:41488607-41488620 chr19:41488609-41488618 chr19:41488607-41488618 chr19:41488607-41488620
29	CEBPB	chr19:41468308-41469019	Hela-S3	cervix:	n/a	chr19:41468797-41468810
30	CEBPB	chr19:41488408-41488845	MCF-7	breast:	n/a	chr19:41488609-41488620 chr19:41488607-41488620 chr19:41488609-41488618 chr19:41488607-41488618 chr19:41488607-41488620
31	CEBPB	chr19:41507207-41507407	H1-hESC	embryonic stem cell:	n/a	n/a
32	CEBPB	chr19:41488438-41488777	K562	blood:	n/a	chr19:41488609-41488620 chr19:41488607-41488620 chr19:41488609-41488618 chr19:41488607-41488618 chr19:41488607-41488620
33	CEBPB	chr19:41488522-41488635	HepG2	liver:	n/a	chr19:41488609-41488620 chr19:41488607-41488620 chr19:41488609-41488618 chr19:41488607-41488618 chr19:41488607-41488620
34	CEBPB	chr19:41488481-41488681	Hela-S3	cervix:	n/a	chr19:41488609-41488620 chr19:41488607-41488620 chr19:41488609-41488618 chr19:41488607-41488618 chr19:41488607-41488620
35	CEBPB	chr19:41506244-41506603	ECC-1	luminal epithelium:	n/a	chr19:41506435-41506446
36	CEBPB	chr19:41468301-41468559	HepG2	liver:	n/a	n/a
37	CEBPB	chr19:41506256-41506628	Hela-S3	cervix:	n/a	chr19:41506435-41506446
38	CEBPB	chr19:41488441-41488804	IMR90	lung:	n/a	chr19:41488609-41488620 chr19:41488607-41488620 chr19:41488609-41488618 chr19:41488607-41488618 chr19:41488607-41488620
39	CEBPB	chr19:41506208-41506618	A549	lung:	n/a	chr19:41506435-41506446
40	CEBPB	chr19:41486382-41486422	K562	blood:	n/a	n/a
41	CEBPB	chr19:41507152-41507489	K562	blood:	n/a	n/a
42	CEBPB	chr19:41468360-41468789	A549	lung:	n/a	n/a
43	CEBPB	chr19:41506189-41507135	A549	lung:	n/a	chr19:41506435-41506446
44	CEBPB	chr19:41488422-41488791	A549	lung:	n/a	chr19:41488609-41488620 chr19:41488607-41488620 chr19:41488609-41488618 chr19:41488607-41488618 chr19:41488607-41488620
45	CEBPB	chr19:41505976-41507518	HCT-116	colon:	n/a	chr19:41506435-41506446
46	CEBPD	chr19:41458422-41458815	K562	blood:	n/a	n/a
47	CHD2	chr19:41465957-41466157	K562	blood:	n/a	n/a
48	CREB1	chr19:41507218-41507529	K562	blood:	n/a	n/a
49	CREB1	chr19:41468563-41468752	A549	lung:	n/a	n/a
50	CREB1	chr19:41486321-41486531	H1-hESC	embryonic stem cell:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr19:41495942-41495992	AG09309	skin:	n/a
2	chr19:41495942-41495992	AG09309	skin:	n/a
3	chr19:41496749-41496799	HMEC	breast:	n/a
4	chr19:41496043-41496093	HCT-116	colon:	n/a
5	chr19:41496043-41496093	AG10803	skin:	n/a
6	chr19:41496043-41496093	GM06990	blood:	n/a
7	chr19:41496749-41496799	AG04449	skin:	fetal
8	chr19:41497222-41497272	NHDF-neo	bronchial:	n/a
9	chr19:41495942-41495992	HepG2	liver:	n/a
10	chr19:41496043-41496093	MCF-7	breast:	n/a
11	chr19:41496749-41496799	HepG2	liver:	n/a
12	chr19:41496043-41496093	NT2-D1	testis:	n/a
13	chr19:41495942-41495992	IMR90	lung:	fetal
14	chr19:41495942-41495992	BE2_C	brain:	n/a
15	chr19:41496043-41496093	HCF	heart:	n/a
16	chr19:41496043-41496093	PANC-1	pancreas:	n/a
17	chr19:41495942-41495992	T-47D	breast:	n/a
18	chr19:41495942-41495992	BJ	skin:	n/a
19	chr19:41495942-41495992	MCF-7	breast:	n/a
20	chr19:41496043-41496093	T-47D	breast:	n/a
21	chr19:41496749-41496799	HEEpiC	esophagus:	n/a
22	chr19:41496749-41496799	SKMC	muscle:	n/a
23	chr19:41496749-41496799	HRPEpiC	eye:	n/a
24	chr19:41496043-41496093	ProgFib	skin:	n/a
25	chr19:41495942-41495992	Jurkat	blood:	n/a
26	chr19:41497222-41497272	LNCaP	prostate:	n/a
27	chr19:41497222-41497272	AG04449	skin:	fetal
28	chr19:41496749-41496799	NB4	blood:	n/a
29	chr19:41496043-41496093	RPTEC	kidney:	n/a
30	chr19:41497222-41497272	IMR90	lung:	fetal
31	chr19:41496043-41496093	HEK293	kidney:	embryo
32	chr19:41496749-41496799	SK-N-MC	brain:	n/a
33	chr19:41496749-41496799	ovcar-3	ovarian:	n/a
34	chr19:41496749-41496799	RPTEC	kidney:	n/a
35	chr19:41496043-41496093	Hela-S3	cervix:	n/a
36	chr19:41496043-41496093	IMR90	lung:	fetal
37	chr19:41496749-41496799	AoSMC	blood vessel:	n/a
38	chr19:41496043-41496093	GM12891	blood:	n/a
39	chr19:41496043-41496093	SKMC	muscle:	n/a
40	chr19:41495942-41495992	H1-hESC	embryonic stem cell:	embryo
41	chr19:41496043-41496093	HRCEpiC	kidney:	n/a
42	chr19:41497222-41497272	GM19239	blood:	n/a
43	chr19:41495942-41495992	HEEpiC	esophagus:	n/a
44	chr19:41495942-41495992	PrEC	prostate:	n/a
45	chr19:41496749-41496799	SAEC	small airway:	n/a
46	chr19:41496749-41496799	MCF10A-Er-Src	breast:	n/a
47	chr19:41496749-41496799	HCM	heart:	n/a
48	chr19:41496043-41496093	CMK	blood:	n/a
49	chr19:41496749-41496799	GM06990	blood:	n/a
50	chr19:41495942-41495992	SK-N-SH	brain:	n/a

No.	Distal block	Cell Line	Cell type
1	chr19:41458951..41460963-chr19:41463374..41465958,2	K562	blood:
2	chr19:41489930..41492049-chr19:41494201..41495851,2	K562	blood:
3	chr19:41463243..41465087-chr19:41467190..41469905,2	K562	blood:
4	chr10:94639799..94640373-chr19:41475219..41475719,2	K562	blood:
5	chr19:41489930..41492049-chr19:41494201..41495851,2	K562	blood:
6	chr19:41458951..41460963-chr19:41463374..41465958,2	K562	blood:
7	chr19:41436490..41439337-chr19:41447432..41449781,2	MCF-7	breast:
8	chr19:41463496..41465246-chr19:41466230..41468956,2	K562	blood:
9	chr19:41455358..41456878-chr19:41467418..41469286,2	K562	blood:
10	chr19:41463243..41465087-chr19:41467190..41469905,2	K562	blood:
11	chr19:41455358..41456878-chr19:41467418..41469286,2	K562	blood:
12	chr19:41480596..41481177-chr19:41649752..41650983,4	K562	blood:
13	chr19:41480412..41481100-chr19:41650028..41650578,2	MCF-7	breast:
14	chr19:41463496..41465246-chr19:41466230..41468956,2	K562	blood:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-CYP2B6-2	chr19:41453006-41453355	ENSG00000269353.1
2	lnc-CYP2B6-1	chr19:41495264-41495408	l_1687_chr19:41492503-41503928_testes
3	lnc-CYP2B6-2	chr19:41452252-41452450	ENSG00000269353.1
4	lnc-CYP2B6-1	chr19:41492504-41492600	l_1687_chr19:41492503-41503928_testes
5	lnc-CYP2B6-1	chr19:41503762-41503928	l_1687_chr19:41492503-41503928_testes
6	lnc-CYP2B6-1	chr19:41493956-41494534	l_1687_chr19:41492503-41503928_testes
7	lnc-CYP2B6-1	chr19:41493177-41493736	l_1687_chr19:41492503-41503928_testes

Variant related genes	Relation type
CYP2B6	TF binding region
ENSG00000269353	TF binding region
CYP2B7P	TF binding region
CYP2B6	CpG island
ENSG00000269353	CpG island
CYP2B7P	CpG island

Extended variants
information (count: 2302 )
Associated
traits (count: 64 )

Variant overlapped rSNPs/rCNVs (count:2302 , 50 per page) page: 1 2 3 4 5 6 7 ... 47

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs113444135	chr19:41447332-41447333	Weak transcription Bivalent Enhancer Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
2	rs73931402	chr19:41447334-41447335	Weak transcription Bivalent Enhancer Enhancers	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
3	rs374430030	chr19:41447340-41447341	Weak transcription Bivalent Enhancer Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
4	rs202166152	chr19:41447365-41447366	Weak transcription Bivalent Enhancer Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
5	rs367658107	chr19:41447410-41447411	Weak transcription Enhancers Bivalent Enhancer	TF binding region	2 gene(s)	Overlapped CNVs	n/a
6	rs12986210	chr19:41447427-41447428	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
7	rs565498717	chr19:41447464-41447465	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
8	rs34151237	chr19:41447479-41447480	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
9	rs34013487	chr19:41447486-41447487	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
10	rs73038475	chr19:41447492-41447493	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
11	rs530114487	chr19:41447496-41447497	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
12	rs548644287	chr19:41447497-41447498	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
13	rs144841281	chr19:41447510-41447511	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
14	rs189816575	chr19:41447515-41447516	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
15	rs148283581	chr19:41447517-41447518	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
16	rs570640829	chr19:41447522-41447523	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
17	rs534541265	chr19:41447528-41447529	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
18	rs552824066	chr19:41447556-41447557	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
19	rs181595797	chr19:41447560-41447561	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
20	rs141247100	chr19:41447565-41447566	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
21	rs559785149	chr19:41447570-41447571	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
22	rs150780446	chr19:41447587-41447588	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
23	rs112958870	chr19:41447592-41447593	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
24	rs202105042	chr19:41447601-41447602	Weak transcription Enhancers Strong transcription Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
25	rs80127325	chr19:41447608-41447609	Weak transcription Enhancers Strong transcription Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
26	rs375617137	chr19:41447612-41447613	Weak transcription Enhancers Strong transcription Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
27	rs35182397	chr19:41447613-41447614	Weak transcription Enhancers Strong transcription Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
28	rs397971751	chr19:41447625-41447626	Weak transcription Enhancers Strong transcription Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
29	rs535723007	chr19:41447626-41447627	Weak transcription Enhancers Strong transcription Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
30	rs75141069	chr19:41447628-41447629	Weak transcription Enhancers Strong transcription Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
31	rs545900475	chr19:41447655-41447656	Weak transcription Enhancers Strong transcription Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
32	rs199651872	chr19:41447661-41447662	Weak transcription Enhancers Strong transcription Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
33	rs185867440	chr19:41447684-41447685	Weak transcription Enhancers Strong transcription Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
34	rs139154745	chr19:41447692-41447693	Weak transcription Enhancers Strong transcription Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
35	rs541692783	chr19:41447715-41447716	Weak transcription Enhancers Strong transcription Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
36	rs560080373	chr19:41447721-41447722	Weak transcription Enhancers Strong transcription Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
37	rs530427368	chr19:41447735-41447736	Weak transcription Enhancers Strong transcription Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
38	rs8107329	chr19:41447738-41447739	Weak transcription Enhancers Strong transcription Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
39	rs79143293	chr19:41447745-41447746	Weak transcription Enhancers Strong transcription Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
40	rs116753629	chr19:41447761-41447762	Weak transcription Enhancers Strong transcription Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
41	rs552625768	chr19:41447768-41447769	Weak transcription Enhancers Strong transcription Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
42	rs74723889	chr19:41447772-41447773	Weak transcription Enhancers Strong transcription Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
43	rs143491124	chr19:41447777-41447778	Weak transcription Enhancers Strong transcription Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
44	rs147166805	chr19:41447781-41447782	Weak transcription Enhancers Strong transcription Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
45	rs8109998	chr19:41447783-41447784	Weak transcription Enhancers Strong transcription Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
46	rs190151188	chr19:41447786-41447787	Weak transcription Enhancers Strong transcription Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
47	rs73933704	chr19:41447788-41447789	Weak transcription Enhancers Strong transcription Flanking Bivalent TSS/Enh	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
48	rs144240843	chr19:41447811-41447812	ZNF genes & repeats Enhancers Weak transcription Strong transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
49	rs182364018	chr19:41447851-41447852	ZNF genes & repeats Enhancers Weak transcription Strong transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
50	rs557831531	chr19:41447862-41447863	ZNF genes & repeats Enhancers Weak transcription Strong transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:64)

Disease	PMID	Source
Myelodysplastic syndrome	17634407	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Cancer	21637783	CNVD
Retinoblastoma	21504564	CNVD
Medulloblastoma	21979893	CNVD
Ovarian cancer	21720365	CNVD
Cancer	20164919	CNVD
Thoracic aortic aneurysm	21092924	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Prostate cancer	18632612	CNVD
Autism	22495311	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Ductal carcinoma	22052326	CNVD
Congenital nephrotic syndrome	18421352	CNVD
Astrocytoma	17934521	CNVD
Leukemia	17361228	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Breast cancer	21858162	CNVD
Breast cancer	17603634	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Endometrial cancer	22040021	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Oligodendroglial tumors	17285580	CNVD
renal disease	20603712	CNVD
Salivary gland adenoid cystic carcinoma	17545515	CNVD
Ovarian cancer	22174824	CNVD
Breast cancer	16608533	CNVD
Neuroblastoma	18923191	CNVD
Breast cancer	21364760	CNVD
Invasive pancreatic ductal carcinoma	18765526	CNVD
Rhabdomyosarcoma	16790082	CNVD
Chordoma	18071362	CNVD
Urothelial carcinoma	21177765	CNVD
small cell lung cancer	20016488	CNVD
Wilms tumour	21544195	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Ovarian neoplasms	16753589	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Metanephric adenoma	20802469	CNVD
Acute myeloid leukemia	16864856	CNVD
Bladder cancer	21909424	CNVD
Medulloblastoma	16783165	CNVD
Gastric cancer	18160780	CNVD
Hepatocellular carcinoma	16750200	CNVD
Basal cell lymphoma	19029149	CNVD
Breast cancer	20409316	CNVD
Diffuse large b-cell lymphoma	19029149	CNVD
Multiple myeloma	16616336	CNVD
Renal cell carcinoma	18765545	CNVD
Acute myeloid leukemia	20729466	CNVD
Lung cancer	18438408	CNVD
Genital abnormality	22378287	CNVD
Hypospadia	22378287	CNVD
Ovarian clear cell carcinoma	19293255	CNVD
Astrocytoma	22246337	CNVD
Non-syndromic sensorineural hearing loss	17431168	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD

Chromatin state (count:251 , 50 per page) page: 1 2 3 4 5 6

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr19:41432200-41447600	Weak transcription	Liver	Liver
2	chr19:41439200-41447800	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
3	chr19:41439200-41448000	Weak transcription	Stomach Mucosa	stomach
4	chr19:41442400-41451400	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
5	chr19:41442600-41450200	Weak transcription	Lung	lung
6	chr19:41444800-41455800	Weak transcription	Fetal Intestine Large	intestine
7	chr19:41445400-41450200	Weak transcription	Fetal Intestine Small	intestine
8	chr19:41445800-41449200	Enhancers	HUVEC	blood vessel
9	chr19:41447200-41447600	Bivalent Enhancer	A549	lung
10	chr19:41447400-41448000	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
11	chr19:41447600-41447800	Flanking Bivalent TSS/Enh	A549	lung
12	chr19:41447600-41448200	Strong transcription	Liver	Liver
13	chr19:41447800-41448200	ZNF genes & repeats	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
14	chr19:41447800-41448200	Bivalent Enhancer	A549	lung
15	chr19:41447800-41448200	Bivalent Enhancer	K562	blood
16	chr19:41448200-41449600	Weak transcription	Liver	Liver
17	chr19:41449600-41451800	Strong transcription	Liver	Liver
18	chr19:41450200-41450400	Bivalent Enhancer	Esophagus	oesophagus
19	chr19:41450200-41450600	ZNF genes & repeats	Lung	lung
20	chr19:41450200-41450800	Strong transcription	Fetal Intestine Small	intestine
21	chr19:41450800-41451800	ZNF genes & repeats	Fetal Intestine Small	intestine
22	chr19:41451400-41451800	ZNF genes & repeats	iPS DF 19.11 Cell Line	embryonic stem cell
23	chr19:41451400-41452200	Flanking Active TSS	K562	blood
24	chr19:41451800-41452200	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
25	chr19:41451800-41455200	Weak transcription	Liver	Liver
26	chr19:41451800-41456200	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
27	chr19:41451800-41456200	Weak transcription	Fetal Intestine Small	intestine
28	chr19:41452200-41452400	Enhancers	K562	blood
29	chr19:41453800-41458200	Weak transcription	Right Atrium	heart
30	chr19:41456200-41456400	ZNF genes & repeats	iPS DF 19.11 Cell Line	embryonic stem cell
31	chr19:41459600-41460800	ZNF genes & repeats	Duodenum Smooth Muscle	Duodenum
32	chr19:41460000-41460800	ZNF genes & repeats	Brain Hippocampus Middle	brain
33	chr19:41460000-41461600	ZNF genes & repeats	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
34	chr19:41460200-41460400	ZNF genes & repeats	A549	lung
35	chr19:41460200-41461400	ZNF genes & repeats	Monocytes-CD14+_RO01746	blood
36	chr19:41464600-41464800	Enhancers	Fetal Intestine Small	intestine
37	chr19:41464800-41466400	Weak transcription	Fetal Intestine Small	intestine
38	chr19:41465200-41466600	Enhancers	Esophagus	oesophagus
39	chr19:41465400-41465800	Bivalent/Poised TSS	ES-UCSF4 Cell Line	embryonic stem cell
40	chr19:41465400-41465800	Active TSS	Breast Myoepithelial Primary Cells	Breast
41	chr19:41465400-41466000	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
42	chr19:41465800-41466000	Bivalent Enhancer	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
43	chr19:41465800-41466000	Flanking Bivalent TSS/Enh	Brain Dorsolateral Prefrontal Cortex	brain
44	chr19:41465800-41466200	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
45	chr19:41465800-41466200	Flanking Bivalent TSS/Enh	ES-UCSF4 Cell Line	embryonic stem cell
46	chr19:41465800-41466200	Flanking Bivalent TSS/Enh	Breast Myoepithelial Primary Cells	Breast
47	chr19:41466000-41466200	ZNF genes & repeats	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
48	chr19:41466000-41466200	Bivalent Enhancer	Adipose Nuclei	Adipose
49	chr19:41466000-41466200	Bivalent Enhancer	Brain Dorsolateral Prefrontal Cortex	brain
50	chr19:41466200-41466600	Bivalent Enhancer	ES-UCSF4 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links